Israeli Hospitals Destroy Tumors With Liquid Nitrogen

IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.

The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.

The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.

Article excerpts from calcalisttech.com

Related Articles

Coca-Cola 'the Real Deal' for Gastrointestinal Clogs


Greek study discovers benefits of carbonated beverage, shows drink can open up clogs in people with convoluted systems.


read more »

Live from Tel Aviv our Executive Director


Last night was a great night for American Friends of Rabin Medical Center as AFRMC founder Arlene Strelitz and I represented all of us in Israel at the opening of the new 54,000 foot Jusidman Emergency and Trauma Center.


read more »

A Surprising Presentation at the RMC 2012 Orthopedic Conference


At this year's Rabin Medical Center Orthopedic Conference in March, attendees were surprised when renowned surgeon Professor Jarvid Parvizi took the stage to give a lecture.


read more »